Microdosing LSD for Alzheimer’s proves safe in early human trial

Posted in Medicine on 20th Dec, 2019
by Alex Muller

New results have been published from one of the first placebo-controlled clinical trials investigating the effects of microdosing LSD. This Phase 1 trial is the first step in testing whether these kinds of psychedelic microdose methods could be useful as a therapeutic approach for treating Alzheimer’s disease